JPMorgan raised the firm’s price target on Glaukos (GKOS) to $120 from $110 and keeps an Overweight rating on the shares. The company reported another “beat and raise” quarter, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GKOS:
- Glaukos price target raised to $113 from $110 at Citi
- Glaukos price target raised to $116 from $104 at BTIG
- Cautious Outlook for Glaukos Amid Regulatory Uncertainty and Valuation Concerns
- Glaukos price target raised to $122 from $120 at Wells Fargo
- Strong Buy Rating for Glaukos Driven by iDose Success and Positive Revenue Projections